BioCentury
ARTICLE | Finance

Chiesi expands rare disease universe

Why Chiesi launched strategic venture fund for rare diseases with Pappas

September 8, 2014 7:00 AM UTC

Chiesi Farmaceutici S.p.A. launched a strategic venture fund focused on rare and Orphan diseases - where the Italian pharma has been busily expanding - with an eye to building a global network of potential collaborators.

Chiesi is the major investor in Chiesi Ventures. A.M. Pappas & Associates will manage the fund and is the other investor...